Company Bioclinica Sa with Fiscal Code 6633214
recorded a turnover of 2024 of
30.773.800,
with a net profit of
3.916.324
and having an average number of employees of
316.
The company operates in the field of Servicii de diagnostic imagistic și activități ale laboratoarelor medicale having the NACE code 8691.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Bioclinica Sa
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
9.979.861
11.555.734
13.247.032
14.752.220
16.208.808
20.657.610
27.856.905
25.504.002
27.502.440
30.773.800
Total Income - EUR
10.055.085
11.633.558
13.318.538
15.073.092
16.496.819
21.198.086
28.422.645
26.377.875
28.110.558
31.599.824
Total Expenses - EUR
8.821.341
10.258.932
11.348.428
13.678.858
15.371.197
18.534.494
22.142.432
22.380.819
24.343.383
27.256.711
Gross Profit/Loss - EUR
1.233.745
1.374.626
1.970.110
1.394.234
1.125.622
2.663.592
6.280.213
3.997.056
3.767.175
4.343.114
Net Profit/Loss - EUR
1.138.022
1.279.395
700.700
1.327.271
1.017.760
2.431.435
5.496.689
3.589.576
3.423.684
3.916.324
Employees
180
196
206
230
286
275
299
293
303
316
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 12.5%, from 27.502.440 euro in the year 2023, to 30.773.800 euro in 2024.
The Net Profit increased by 511.773 euro, from 3.423.684 euro in 2023, to 3.916.324 in the last year.
Check the financial reports for the company - Bioclinica Sa
Financial Rating - BIOCLINICA SA
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Bioclinica Sa
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Bioclinica Sa
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Bioclinica Sa
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Bioclinica Sa - CUI 6633214
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
5.361.184
5.888.932
5.722.585
6.603.689
6.953.076
7.094.516
7.101.693
6.594.550
6.462.760
6.908.925
Current Assets
1.917.236
2.185.128
2.562.896
3.260.751
3.378.592
5.533.099
8.281.673
9.035.385
10.381.023
10.313.406
Inventories
438.838
500.764
528.410
645.194
831.343
1.304.022
1.140.811
1.288.881
1.431.862
1.443.050
Receivables
1.468.165
1.666.141
1.919.902
2.278.008
2.143.201
2.437.051
1.871.340
2.617.041
3.197.447
2.560.928
Cash
10.233
16.614
112.488
337.504
404.048
1.792.026
5.269.264
5.129.462
5.751.714
6.309.428
Shareholders Funds
3.782.485
5.023.304
5.639.001
6.862.787
7.536.910
9.640.419
11.436.220
10.600.160
12.980.884
12.403.200
Social Capital
22.497
22.268
21.891
21.489
21.073
20.674
20.215
20.278
20.216
20.103
Debts
3.517.657
3.073.584
2.684.632
3.027.370
2.826.765
3.016.950
3.973.298
5.061.805
3.907.071
4.861.860
Income in Advance
0
0
0
0
2.744
5.656
5.903
7.989
8.954
7.031
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8691 - 8691"
CAEN Financial Year
8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
10.313.406 euro in 2024 which includes Inventories of
1.443.050 euro, Receivables of
2.560.928 euro and cash availability of
6.309.428 euro.
The company's Equity was valued at
12.403.200 euro, while total Liabilities amounted to
4.861.860 euro.
Equity decreased by -505.137 euro, from 12.980.884 euro in 2023, to 12.403.200 in 2024.
The Debt Ratio was 28.1% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Bioclinica Sa